Cargando…

The effects of ARID1A mutation in gastric cancer and its significance for treatment

Gastric cancer (GC) has emerged as a significant issue in public health all worldwide as a result of its high mortality rate and dismal prognosis. AT-rich interactive domain 1 A (ARID1A) is a vital component of the switch/sucrose-non-fermentable (SWI/SNF) chromatin remodeling complex, and ARID1A mut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Shan, Duan, Ruifeng, Cong, Liang, Song, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676575/ https://www.ncbi.nlm.nih.gov/pubmed/38008753 http://dx.doi.org/10.1186/s12935-023-03154-8

Ejemplares similares

Therapeutic significance of ARID1A mutation in bladder cancer
por: Conde, Marina, et al.
Publicado: (2022)

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Significant Impacts of Increasing Aridity on the Arid Soil Microbiome
por: Neilson, Julia W., et al.
Publicado: (2017)

Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer
por: Kim, Jun Yong, et al.
Publicado: (2023)

Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma
por: Zhou, Huan, et al.
Publicado: (2019)

Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma
por: Zhang, Zhenkun, et al.
Publicado: (2023)

Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy
por: Gu, Yun, et al.
Publicado: (2022)

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
por: Lee, Dakeun, et al.
Publicado: (2017)

Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers
por: Khalique, Saira, et al.
Publicado: (2018)

ARID1A alterations and their clinical significance in cholangiocarcinoma
por: Namjan, Achira, et al.
Publicado: (2020)

Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis
por: Kim, Young-Sik, et al.
Publicado: (2017)

Prognostic role of ARID1A negative expression in gastric cancer
por: Ashizawa, Mai, et al.
Publicado: (2019)

Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance
por: Ren, Jun, et al.
Publicado: (2018)

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
por: Johnson, Radia M., et al.
Publicado: (2022)

ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016)

Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
por: Zhao, Xue-Song, et al.
Publicado: (2019)

Relevance of ARID1A Mutations in Endometrial Carcinomas
por: De Leo, Antonio, et al.
Publicado: (2022)

Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer
por: Silva-Oliveira, Rita, et al.
Publicado: (2020)

Expression of MACC1 and c-Met in human gastric cancer and its clinical significance
por: Guo, Tiankang, et al.
Publicado: (2013)

ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms
por: Zhao, Shankun, et al.
Publicado: (2021)

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
por: Fukumoto, Takeshi, et al.
Publicado: (2018)

ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer
por: Li, Lin, et al.
Publicado: (2019)

ARID1A-mutated ovarian cancers depend on HDAC6 activity
por: Bitler, Benjamin G., et al.
Publicado: (2017)

The significance of LRPPRC overexpression in gastric cancer
por: Li, Xiaosa, et al.
Publicado: (2013)

ARID1A/BAF250a is significantly overexpressed in primary invasive breast cancer
por: Szpon, Łukasz, et al.
Publicado: (2020)

ARID1B is a specific vulnerability in ARID1A-mutant cancers
por: Helming, Katherine C., et al.
Publicado: (2014)

Expression of gremlin1 in gastric cancer and its clinical significance
por: Yamasaki, Yoichi, et al.
Publicado: (2018)

The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer
por: Zhou, Zhouyi, et al.
Publicado: (2015)

Expression of POT1-AS1 in GC Tissue, Its Effect on Biological Behavior of Gastric Cancer, and Its Significance on Prognosis of Gastric Cancer
por: Jiang, Li, et al.
Publicado: (2022)

Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response
por: Niedermaier, B., et al.
Publicado: (2019)

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Wang, Dan-dan, et al.
Publicado: (2012)

Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer
por: Qadir, Jasiya, et al.
Publicado: (2021)

ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
por: Cheng, Xuan, et al.
Publicado: (2021)

Retracted: Expression of POT1-AS1 in GC Tissue, Its Effect on Biological Behavior of Gastric Cancer, and Its Significance on Prognosis of Gastric Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Erratum to: The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer
por: Zhou, Zhiyi, et al.
Publicado: (2015)

Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour
por: Wang, Ya-Wen, et al.
Publicado: (2014)

Clinical significance of ubiquilin 1 in gastric cancer
por: Bao, Jingjing, et al.
Publicado: (2018)

The effects of ARID1A mutations on colorectal cancer and associations with PD‐L1 expression by stromal cells
por: Kamori, Tomohiro, et al.
Publicado: (2021)

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis
por: Yachida, Nozomi, et al.
Publicado: (2020)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nbhcabuf81ft5casek32i5f9us